Abstract
Medical
coding has been in practice in US, and UK markets, and some parts of Europe.
However, its penetration to the other world countries has not been seen so far.
Coding practices bring harmonization in the overall practice of the medical
field. The present Letter to Editor has been written to suggest coding
practices in Pharmacological research and coding practices in pre – clinical
and clinical trials. Hope this will add to the overall improvement in the
practices of this very imperative field of medical and pharmaceutical science.
Keywords:
Coding in Pre-clinical trials, Coding in Pharmacological research
Pharmacological
research and pre-clinical trials are one of the foundation practices in order
to find a suitable drug or medicine. Pharmacological research involves animal
handling, and drug dosing at different interval of time. In order to find a
suitable drug effective for any particular targeted disease, lot of lead
compounds are tested on animals and different models are applied and
experimented upon. However, till date precision based data monitoring of these
research activities and for sake in pre-clinical trials the monitoring to the detail
hasn’t been in the practice. This makes the planning of budget for these
research activities bit cumbersome and difficult.
In
order, to find accurate budgeting and monitoring of pharmacological research
and pre-clinical trials, coding practices shall be initiated while conducting
such research activities. Reason being, the cost incurred while conducting such
trials and research could be documented, and it would help in further proper
estimation of budget requirements to conduct such trials and research
activities effectively and efficiently. Like in Medical coding, I would
suggest, Pre-clinical trial coding practices to be initiated across the world,
as it would help in harmonization of these trials at global level. This would
not only help in monitoring the pharmacological research activities at global
level anywhere across the world, but, would also help in highlighting any
loopholes or fake claims being made while conducting such trials.
There
are lot of incidents in research arena across the world, where fake trials have
been reported in order to approve the drugs, which may have superficial or
spurious actions later when such drugs after passing through such trials are
launched in the market. This is a big threat. So, the best practices, is to
include, a monitoring system based at global location and centralized location
which can monitor any loopholes or ill practices while conducting especially
pre-clinical trials or animal research the basic foundation of pharmacological
research.
The
cost of launching spurious drugs in the market, is huge, not in terms of the
cost involved in manufacturing such drugs at a large scale but also considering
the risk it poses to health of the population for which a particular drug is
research in order to mitigate the disease or its effects.
Pre-clinical
trial coding and Pharmacological Research Coding will have positive cause and
effect consequence’s in future of any drug research. Hence, its highly being
suggested to bring harmonization in the research activities in pharmacology
arena and penalize the culprits who are doing wrong practices in order to pass
their lead compounds just in order to have fake trial approvals and mint money
by selling such drugs, and running away with the money made from such spurious
drugs sales. 1
Reference
1. Devansh
Mehta. Clinical Research and Clinical Trial Coding: A New Perspective. Inventi
Rapid: Clinical Research, 016(4):1-1, 2016.
Comments
Post a Comment